Haleon, carved out of British drugmaker last July in the biggest listing in Europe for more than a decade, is the world’s biggest standalone consumer health business selling non-prescription drugs, vitamins and oral care products.
Featured Posts
There’s no shortage of information dedicated to reconciling the rewards and risks of cell and gene therapies, and how payers and employers can best provide access to potentially transformative treatments while factoring in price and affordability. We believe that the classical game theory paradox, the “prisoner’s dilemma,” may provide useful insights in helping the various stakeholders develop solutions for how best to cover CGTs.
Roche’s Genentech Inc. sued Biogen MA Inc. on Tuesday in San Francisco federal court, claiming Biogen owes additional patent royalties from worldwide sales of its blockbuster multiple-sclerosis and Crohn’s disease drug Tysabri.
Novavax Inc.’s shares plunged 28% in U.S. early trading on Wednesday, a day after the COVID-19 vaccine maker raised doubts about its ability to remain in business.
Pfizer Inc. and its German partner BioNTech SE (22UAy.DE) have applied for emergency use authorization of their Omicron-adapted COVID-19 vaccine in the United States as a booster dose for children aged six months through four years, the companies said on Wednesday.
Citing lack of efficacy evidence, the FDA rejected Cytokinetics’ heart failure hopeful omecamtiv mecarbil in a Tuesday evening decision.
Shares of Reata Pharmaceuticals Inc. soared 175% to hit a one-year high in early trading on Wednesday, after the U.S. Food and Drug Administration (FDA) approved its rare disease drug and ended years of uncertainty over its future.
Eli Lilly and Co. will cut list prices by 70% for its most commonly prescribed forms of insulin, Humalog and Humulin, beginning from the fourth quarter of this year, the drugmaker said on Wednesday.
Tuesday, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) deemed there were enough data to support Pfizer’s respiratory syncytial virus (RSV) vaccine RSVpreF in adults aged 60 and older.
European Commission President Ursula von der Leyen’s silence about her dealings with drugmaker Pfizer leading to the EU’s biggest COVID-19 vaccine contract is hurting public trust and is a problem that will not go away, its ombudsman said.